Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

149.70
-1.0500-0.70%
Post-market: 149.700.00000.00%19:11 EDT
Volume:1.16M
Turnover:173.82M
Market Cap:285.63B
PE:20.94
High:151.11
Open:149.67
Low:149.31
Close:150.75
52wk High:170.46
52wk Low:97.72
Shares:1.91B
Float Shares:1.82B
Volume Ratio:0.68
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:3.12%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.19
PE(LYR):20.94

Loading ...

Novartis Says 1 in 4 Breast Cancer Patients Treated With Kisqali Progression-Free Beyond 4 Years

MT Newswires Live
·
Dec 09, 2025

Novartis Says Phase 3 Ianalumab Study Showed Extended Immune Thrombocytopenia Disease Control

MT Newswires Live
·
Dec 09, 2025

Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster

Benzinga_recent_news
·
Dec 09, 2025

Novartis to Collaborate With Relation to Discover New Atopic Disease Targets

MT Newswires Live
·
Dec 09, 2025

Novartis AG (NVS.US) Bets $1.7 Billion on UK AI Biotech to Target Allergic Diseases

Stock News
·
Dec 09, 2025

Novartis Shares Rise After Morgan Stanley Upgrade

MT Newswires Live
·
Dec 04, 2025

Top Calls on Wall Street: Nvidia, Apple, Amazon, Oracle, Marvell, Broadcom, ASML, American Eagle, and More

Tiger Newspress
·
Dec 03, 2025

Morgan Stanley Upgrades Novartis to Overweight From Equal Weight, $136 Price Target

MT Newswires Live
·
Dec 03, 2025

U.S., U.K. Strike Deal on Higher Drug Prices -- WSJ

Dow Jones
·
Dec 02, 2025

FDA Decision Opens Bigger Market for Novartis's Blockbuster Gene Therapy -- Barrons.com

Dow Jones
·
Nov 26, 2025

Sector Update: Health Care Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Nov 25, 2025

Top Calls on Wall Street: Nvidia, Apple, Tesla, Microsoft, Oracle, Vistra Energy, Coinbase & More

Tiger Newspress
·
Nov 25, 2025

Market Chatter: Novartis to Eliminate Up to 550 Roles at Stein Facility in Switzerland

MT Newswires Live
·
Nov 25, 2025

Novartis Drug for Spinal Muscular Atrophy Gets FDA Approval

Dow Jones
·
Nov 25, 2025

J.P. Morgan Sticks to Its Hold Rating for Novartis (NVS)

TIPRANKS
·
Nov 21, 2025

Biotech Reawakens: Policy Clarity, Breakthrough Data and a Surge in M&A

LiveWire
·
Nov 21, 2025

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

Benzinga
·
Nov 21, 2025

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Jobs Data

MT Newswires Live
·
Nov 20, 2025

Novartis Rolls Forward Mid-Term Sales Outlook to 2025-2030, Expects Over 5% to 6% Sales CAGR

MT Newswires Live
·
Nov 20, 2025

Novartis Expects Key Drugs, Recent Deals to Buoy Sales Into 2030s -- Update

Dow Jones
·
Nov 20, 2025